PKTX logo

ProtoKinetix, Incorporated Stock Price

OTCPK:PKTX Community·US$2.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PKTX Share Price Performance

US$0.007
-0.00 (-22.22%)
US$0.007
-0.00 (-22.22%)
Price US$0.007

PKTX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

ProtoKinetix, Incorporated Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$375.8k

Other Expenses

-US$375.8k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.00096
0%
0%
0%
View Full Analysis

About PKTX

Founded
1999
Employees
n/a
CEO
Clarence Smith
WebsiteView website
www.protokinetix.com

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

Recent PKTX News & Updates

Recent updates

No updates